Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial
- 824 Downloads
Oxidative stress has a key role in the pathogenesis of type II diabetes mellitus (T2DM) and its vascular complications. Antioxidant therapy has been suggested as a potential approach to blunt T2DM development and progression. The aim of this study was to assess the effects of supplementation with curcuminoids, which are natural polyphenolics from turmeric, on oxidative indices in diabetic individuals.
In this randomized double-blind placebo-controlled trial, 118 subjects with T2DM were randomized to curcuminoids (1000 mg/day co-administered with piperine 10 mg/day) or matching placebo for a period of 8 weeks. Serum total antioxidant capacity, superoxide dismutase (SOD) activities and malondialdehyde (MDA) concentrations were measured at baseline and after the supplementation period.
Curcuminoids supplementation caused a significant elevation in serum total antioxidant capacity (TAC) (p < 0.001) and SOD activities (p < 0.001), while serum MDA levels were significantly reduced compared with the placebo group (p < 0.001). These results remained statistically significant after adjustment for potential confounders (baseline differences in body mass index and fasting serum insulin).
The present results support an antioxidant effect of curcuminoids supplementation in patients with T2DM, and call for future studies to assess the impact of these antioxidant effects on the occurrence of diabetic complications and cardiovascular endpoints.
KeywordsCurcumin Diabetes mellitus Oxidative stress Malondialdehyde Total antioxidant capacity Superoxide dismutase
This study was financially supported by Clinical Trial Research Center (Tehran, Iran). The authors gratefully acknowledge Sami Labs LTD (Bangalore, India) for providing the drug material used in this trial.
Compliance with ethical standards
Conflict of interest
Muhammed Majeed is the CEO of Sabinsa Corporation and Sami Labs Ltd.
- Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimer’s Dis 6:367–377Google Scholar
- Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, Ghayour-Mobarhan M (2015) An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial Chinese journal of integrative medicine 21:332–338. doi: 10.1007/s11655-015-2160-z PubMedGoogle Scholar
- Ghandadi M, Sahebkar A (2016) Curcumin: an effective inhibitor of interleukin-6. Curr Pharm Des. doi: 10.2174/1381612822666161006151605
- Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M (2012a) Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr 108:1272–1279. doi: 10.1017/S0007114511006544 CrossRefPubMedGoogle Scholar
- Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A (2014a) Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement Ther Med 22:851–857. doi: 10.1016/j.ctim.2014.07.006 CrossRefPubMedGoogle Scholar
- Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A (2015b) Short-term curcuminoid supplementation for chronic pulmonary complications due to sulfur mustard intoxication: positive results of a randomized double-blind placebo-controlled trial. Drug Res 65:567–573. doi: 10.1055/s-0034-1389986 Google Scholar
- Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A (2015c) Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clin Nutr 34:1101–1108. doi: 10.1016/j.clnu.2014.12.019 CrossRefPubMedGoogle Scholar
- Panahi Y, Ghanei M, Hajhashemi A, Sahebkar A (2016b) Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. J Diet Suppl 13:93–105. doi: 10.3109/19390211.2014.952865 CrossRefPubMedGoogle Scholar
- Panahi Y, Hosseini MS, Khalili N, Naimi E, Simental-Mendia LE, Majeed M, Sahebkar A (2016c) Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post hoc analysis of a randomized controlled trial. Biomed Pharmacother Biomedecine Pharmacotherapie 82:578–582. doi: 10.1016/j.biopha.2016.05.037 CrossRefPubMedGoogle Scholar
- Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A (2016d) Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol 68:223–229. doi: 10.1097/FJC.0000000000000406 CrossRefPubMedGoogle Scholar
- Sahebkar A (2010) Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril 94:e75–e76; author reply e77. doi: 10.1016/j.fertnstert.2010.07.1071
- Uchegbu NN, Ishiwu CN (2016) Germinated Pigeon Pea (Cajanus cajan): a novel diet for lowering oxidative stress and hyperglycemia. Food Sci NutrGoogle Scholar
- Zabihi NA, Pirro M, Johnston TP, Sahebkar A (2016) Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des. doi: 10.2174/1381612822666161010115235